Longevity for Men 40+

Your 40s are the single most useful turning point of your adult life. Most men miss it because they still feel fine. That is the problem.

Atherosclerosis (the slow buildup of plaque inside your arteries) does not begin in your 60s. It starts in your 20s and 30s. By the time you turn 40, it is already quietly advanced in a meaningful minority of men who feel perfectly healthy and have no clue. The 2019 European Society of Cardiology dyslipidaemia guidelines (European Heart Journal) put the strategy plainly: the goal is to reduce lifetime exposure to artery-clogging particles, not to wait around for symptoms.

The particle that drives most of the damage is apolipoprotein B (ApoB, a single number that counts every artery-clogging lipoprotein, including LDL, VLDL, IDL, and lipoprotein(a)). Standard total cholesterol and LDL-C miss the true particle count in roughly a quarter of men, especially those with metabolic syndrome or insulin resistance. Asking your doctor for one ApoB measurement in your 40s is one of the highest-value blood draws of your life. We go deep on this in the ApoB and Lp(a) guide.

Then there's lipoprotein(a), Lp(a). It is genetically set, sticks with you your entire life, and is barely touched by statins. The 2022 European Atherosclerosis Society consensus (European Heart Journal) says to measure Lp(a) at least once in adulthood for every adult, not just men with a family history. Elevated Lp(a) flags higher cardiovascular risk above roughly 50 mg/dL (~125 nmol/L). Levels near 100 mg/dL roughly double your atherosclerotic cardiovascular risk, which should change how aggressively you and your doctor manage everything else.

In your 40s you are not treating disease. You are buying decades. And the cheapest decade to buy is the one that has not started yet.

No topic in men's health is more distorted by aggressive marketing than testosterone. A real medical condition (hypogonadism, meaning testosterone below the clinical threshold plus symptoms) sits right next to a real lifestyle effect (a modest age-related decline). They need very different responses. Confusing them is how men end up on therapy they don't actually need.

The age effect is modest, not catastrophic. Total testosterone drops on average by roughly 1% per year after age 30, with a wider 1 to 2% range in some studies, and the spread between individual men is huge. The European Male Aging Study (NEJM 2010) found that genuine late-onset hypogonadism (low testosterone plus symptoms) affects only about 2% of men aged 40 to 79. Other men with somewhat lower readings usually sit inside the wide normal range, or have values driven by obesity, untreated sleep apnea, alcohol, or chronic stress. All of which are reversible.

When TRT is actually indicated. The Endocrine Society's 2018 clinical practice guideline is clear: testosterone replacement is for men with consistently low total testosterone on two separate morning measurements, plus real symptoms of androgen deficiency. European urological guidance agrees with this symptom-driven approach. A single borderline-low result while you are stressed or sleep-deprived is not a diagnosis. It's a snapshot of a bad week.

The big cardiovascular safety question. The TRAVERSE trial (NEJM 2023) was the largest randomized cardiovascular safety trial of testosterone in middle-aged and older men with hypogonadism and existing cardiovascular risk factors. It found testosterone replacement non-inferior to placebo for major adverse cardiovascular events over a mean 33 months of follow-up. That's reassuring for the indicated population. It is not an endorsement of testosterone as an anti-aging supplement for men with normal levels.

The fine print on TRAVERSE. The same trial reported higher rates of atrial fibrillation (3.5% vs 2.4%), acute kidney injury (2.3% vs 1.5%), and pulmonary embolism (0.9% vs 0.5%) in the testosterone arm versus placebo. The headline cardiovascular result is reassuring, but these other signals belong in any honest informed-consent conversation. That goes double for men with prior blood clots, kidney disease, or rhythm issues. The full picture is laid out in the HRT and TRT guide.

Lifestyle still matters, but only so much. Sleep, body composition, training, alcohol, and metabolic health all affect your own testosterone, but the effect sizes are modest. There is no validated 'natural T-booster' supplement on the market. Anyone selling you one is selling you a feeling, not a measured result.

Be careful with low-T clinics. Some clinics push testosterone hard at men whose levels are not actually clinically low. Insist on two morning measurements, a real symptom assessment, a check for obesity and sleep apnea first, and a doctor, not a salesperson with a prescription pad.

Lean muscle mass and grip strength predict all-cause mortality across many large studies. Muscle is also where most of your whole-body insulin sensitivity lives. And this decade is the cheapest one in which to protect it.

Strength, not size, defines the risk. The revised European consensus on sarcopenia (EWGSOP2, Age and Ageing 2019) defines sarcopenia (age-related loss of muscle) mainly by low muscle strength, confirmed by muscle quantity and quality. Screening is simple: how heavy you can lift, how fast you can stand from a chair, and how strong your grip is. If you lose strength faster than average across your 40s and 50s, sarcopenia in your 70s becomes much more likely.

Resistance training is non-negotiable. Two to four sessions per week, covering squat, hinge, push, pull, and carry, is the most evidence-backed activity pattern for healthspan in midlife. Progressive overload matters more than the split you choose. Pair it with regular zone 2 cardio and the odd higher-intensity session. Large prospective analyses consistently show that meeting and exceeding physical-activity guidelines goes hand in hand with substantially lower all-cause mortality, in healthy adults and in patients with established cardiovascular disease alike.

Protein, more than you think. Protein needs rise with age, not fall, and that matters a lot in your 40s. Expert consensus for older adults recommends roughly 1.0 to 1.2 g protein per kg body weight per day, going higher (up to ~1.5 g/kg/day) for active or recovering men. The practical lesson: hit a real protein target at most meals, especially breakfast, where many men under-eat protein and over-eat refined carbs.

Don't fear the weights. Compound lifts at moderate-to-high effort, with reasonable form and enough recovery, are not dangerous for healthy adults. They actively protect against falls, fractures, and metabolic disease later in life. If you have never trained seriously before, hire a coach for six to twelve weeks. The technique you learn at 45 will pay back across the rest of your life.

Cardiovascular disease is still the leading cause of death for men in the US and DACH. Your 40s and 50s are the window where most fixable damage gets done, and also where most prevention actually works.

Get the numbers your standard panel skips. Beyond total cholesterol and LDL-C, ask once for ApoB, Lp(a), HbA1c, fasting insulin (or HOMA-IR), high-sensitivity CRP (hsCRP), and a basic liver panel. The 2019 ESC/EAS dyslipidaemia guideline puts the weight on risk-based LDL and ApoB targets. That means your 'normal' lab range is not the same as your individual target if you carry elevated Lp(a), a strong family history, or metabolic syndrome. The ApoB and Lp(a) guide explains how to read these numbers together.

Measure blood pressure at home. Get accurate readings at home, not just at the doctor's office. White-coat effects routinely add 5 to 15 mmHg to clinic readings. A cheap upper-arm cuff (not a wrist one) used correctly is one of the best longevity investments you can make under 50 euros.

Visceral fat is a real risk factor. Waist circumference is crude but genuinely useful, and worth tracking. A waist above ~94 cm (37 in) raises metabolic risk. Above ~102 cm (40 in), it raises it a lot more. The mechanism linking belly fat, insulin resistance, fatty liver, and cardiovascular disease is the same, so fixing one usually helps all the others.

Alcohol: the honest reckoning. The largest individual-participant meta-analysis of nearly 600,000 drinkers (Lancet 2018) found that all-cause mortality risk climbed above roughly 100 g of pure alcohol per week. That's about 7 US standard drinks, ~12 UK units, or ~8 to 10 German Standardgetränke, and there is no clean 'protective dose' hiding in the data. If your social life runs through Wiesn, Stammtisch, après-ski, or the office Friday round, the goal is honest awareness, not moralism. Swapping one or two heavy weeks per month for light or alcohol-free ones is realistic and meaningful. Alkoholfreies Bier exists, and by the mortality data, it is a better friend than its alcoholic cousin.

Smoking. If you still smoke, this is the single most useful thing you can change in your 40s, and honestly nothing else on this page comes close. Vaping is not a long-term solution, but as a bridge off cigarettes, it beats continuing to smoke.

How much sleep you actually need. Adult sleep consensus broadly recommends 7 to 9 hours per night. Habitual short sleep is linked to cardiovascular disease, metabolic disease, dementia risk, and lower testosterone. If you've been telling yourself for years that you do fine on six, you almost certainly do not.

Sleep apnea is the hidden engine. Obstructive sleep apnea (OSA, repeated airway collapses during sleep) is badly underdiagnosed in men over 40, especially those who snore, are overweight, or carry a thick neck. It quietly drives high blood pressure, fatigue, atrial fibrillation, and low testosterone. That last link matters more than most men realize when they read a low T number on a lab slip. Untreated OSA is one of the most common reversible causes of low testosterone in midlife men, which is exactly why the Endocrine Society guideline tells doctors to screen for it before reaching for the prescription pad. If your partner reports snoring or pauses in your breathing, or you wake up unrefreshed, ask your Hausarzt about a screening sleep study. Many cases improve a lot with weight loss, positional therapy, or CPAP.

Depression in midlife men looks different. It often shows up as irritability, withdrawal, loss of interest, heavier drinking, and a feeling of being 'flat' rather than as classic sadness. Many men spend years blaming this on work stress or low testosterone when the real issue is depression. Suicide rates in middle-aged men in DACH and the US stay stubbornly high. If something feels wrong for more than a couple of weeks, talk to your doctor. Or in Germany, call the Telefonseelsorge 0800 111 0111 (free, 24/7) or Männerhilfetelefon 0800 123 99 00 (Mon to Thu 08 to 20, Fri 08 to 15; the operator's current scope explicitly covers domestic, sexualised, psychological, stalking, bullying, childhood, digital and forced-marriage abuse, and broader distress beyond physical violence). In Austria, Telefonseelsorge 142. In Switzerland, Die Dargebotene Hand 143. In the US, the 988 Suicide & Crisis Lifeline. Asking for help is not a hormone problem.

The PSA question, without the cheerleading. Prostate cancer screening is one of the most contested topics in men's health, and it deserves more than a thumbs-up or thumbs-down answer. The European ERSPC trial (European Urology 2019) showed that PSA screening cuts prostate-cancer-specific mortality by about 20% at 16 years of follow-up. The US PLCO trial showed a smaller effect, partly because its 'control' arm was heavily contaminated with off-protocol PSA testing that washed out the difference between groups.

The other side of the argument is just as real. The PIVOT trial (NEJM 2017) randomized men with localized prostate cancer to radical prostatectomy versus observation, and found no significant difference in all-cause or prostate-cancer mortality over nearly 20 years of follow-up. A 2017 population analysis (Hu et al., BJU International) similarly raised hard questions about overdiagnosis and overtreatment, with side effects (incontinence, erectile dysfunction) that are not at all trivial for the men who live with them. Major evidence reviews now accept that PSA screening cuts prostate-cancer mortality modestly, while also causing real harms downstream from biopsy and treatment.

Current US and European guidance broadly lands on shared decision-making starting at age 45 to 50 (earlier for Black men, BRCA carriers, or men with a strong family history), using a baseline PSA to set how often you follow up. The right answer is a conversation, not a reflex test ordered without context. The goal is to find the cancers that would have killed you, and to leave the harmless ones alone.

Most men in DACH and the US under-use the check-ups they already have access to. Here's a realistic structure for your 40s.

Germany. Statutory insurance covers the Gesundheits-Untersuchung (formerly Check-up 35), generally every three years from age 35. It includes blood pressure, a basic blood glucose and cholesterol panel, urine, and a clinical exam. It does not include ApoB, Lp(a), fasting insulin, hsCRP, or a detailed hormone panel. Most of these are available as IGeL or Selbstzahler add-ons through your Hausarzt or a preventive-medicine practice. Ask for them explicitly.

Austria. The Vorsorgeuntersuchung is broadly similar and free for insured residents from age 18. Many men also see a Wahlarzt for fast access to a urologist or andrologist, with partial Krankenkasse reimbursement. For testosterone or PSA-based decisions, a Wahlarzt urologist is often the most practical route.

Switzerland and the United States. In Switzerland, basic insurance covers doctor visits after the deductible. Preventive blood panels beyond the basics are usually patient-pay. In the US, the standard annual physical is similar to DACH. Ask explicitly for ApoB, Lp(a), HbA1c, fasting insulin, hsCRP. Direct-to-consumer labs are widely available; bring the results to your doctor.

A practical menu in your 40s. Once: Lp(a), full lipid panel including ApoB, HbA1c, fasting insulin, hsCRP, TSH, ferritin, vitamin D, total testosterone (morning), SHBG, baseline PSA. Discuss a baseline ECG. Annually or every two years: home blood pressure, lipid panel, HbA1c, basic metabolic panel, weight and waist, plus a sleep and alcohol review. From the late 40s: a coronary artery calcium (CAC) score if your cardiovascular risk is intermediate or your family history is strong; colonoscopy from 45 in the US, 50 in DACH (earlier with family history); an ongoing PSA discussion.

The point of a check-up is not to chase numbers. It's to build a relationship with one trusted doctor who knows your trajectory. The men who do well in their 70s mostly started this in their 40s.